drugset / Trial / NCT01571908

Rapid Sequence Intubation With Magnesium-rocuronium Compared With Succinylcholine - A Randomised Clinical Study

NCT01571908 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Magnesium accelerates the reaction of rocuronium, a neuromuscular blocker used for muscle relaxation to ease the intubation during anaesthesia. Succinylcholine is a very fast reacting neuromuscular blocker. It is often used in emergency procedures, when rapid intubation is necessary. We want to now if a perfusion of magnesium before anaesthesia accelerates to such an extent the reaction of rocuronium that intubation conditions are comparable or even better than with succinylcholine alone (prior perfusion of saline=placebo)

Timeline

Start
2012-09
Primary completion
2015-07
Completion
2015-07

Outcome

Missed primary endpoint

paper The analysis adjusted for gender and center showed no superiority of MgSO4-rocuronium compared with saline-succinylcholine (relative risk [RR] 1.06, 95% confidence interval [CI], 0.81-1.39, P = .659). PMID 33337797 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 60 mg/kg Intravenous
Subject Rocuronium Other / unclassified 0.6 mg/kg Intravenous
Comparator Suxamethonium Other / unclassified 1 mg/kg Intravenous

Indications

No indication recorded.